Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib is a research paper published in British Journal of Haematology (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P30CA91842
National Institutes of Health
Grant: P01CA101937
National Institutes of Health
Grant: R01HL134952
National Institutes of Health
Grant: T32HL007088
NCI NIH HHS
Grant: P30 CA091842
FWCI
2.59
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords